BioTechGrid – Page 2237

Fibrosis-focused Tvardi to go public via merger with cash-strapped Cara

December 18, 2024

Pruritus drug developer Cara Therapeutics kicked off the year halving its headcount, and the biotech has now found a new…

Biotechnology

Merck & Co. boosts GLP-1 portfolio by paying $112M upfront for Hansoh’s preclinical drug

December 18, 2024

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for…

Biotechnology

Aurion’s regenerative eye disease med improves vision in phase 1/2 trial

December 18, 2024

The highest dose of Aurion Biotech’s cell therapy, the main component of which recently received approval in Japan, has improved…

Biotechnology

Cognition’s phase 2 SHIMMER results finally allow dementia drug to shine

December 18, 2024

The failure of Cognition Therapeutics’ Alzheimer’s disease candidate CT1812 in the SHINE trial earlier this year may have rubbed off…

Genetics

Nvidia’s Venture Arm Raises Stake in AI Drug Discoverer Genesis Therapeutics

December 18, 2024

Evan Feinberg, PhD, founder and CEO of Genesis Therapeutics In the beginning, Genesis Therapeutics spun out from the Stanford University…

Genetics

How the Inflammatory Process Is Influenced by the Circadian Rhythm

December 18, 2024

There are various studies that have explored the role of the body’s circadian rhythm in regulating immune activity. Disruptions in…

Biotechnology

Novo Nordisk taps Photys for $186M cardiometabolic collab

December 17, 2024

With Novo Nordisk’s name already synonymous with treatments for diabetes and obesity, the Danish drugmaker has been making a concerted…

Biotechnology

Novo Holdings leads SiteOne’s $100M series C for non-opioid pain treatments

December 17, 2024

SiteOne Therapeutics is powering up with $100 million to advance its early pipeline of non-opioid therapeutics that target the peripheral…

Genetics

Ketamine Keeps Zebrafish from Giving up by Overstimulating Astroglia

December 17, 2024

The anesthetic ketamine could be a game changer for treating severe depression, but there are still many questions about how…

Medical Technology

BD, Babson Diagnostics expand fingertip blood draws to urgent care clinics, doctors’ offices

December 17, 2024

Longtime partners in simplifying blood sample collection and testing, BD and Babson Diagnostics are now making their miniaturized approach available…

Atomic interfaces toughen diamond composites with multi-walled carbon nanotube networks

Comprehensive Review of Benchmark Datasets for Deep Learning in Medical Image Segmentation

New Method Uses Noisy Samples More Efficiently While Accounting for Uncertainty

MSSARN: A Multi-Layer Spectral-Spatial Attention Residual Network for Hyperspectral Image Classification

Isolated SACSIN HEPN Domain Exhibits RNA-Binding Activity

TUDCA restores maturation of aged eggs in vitro by reducing ER stress

Exploring the Future of Healthcare with Panos Karelis

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

Fibrosis-focused Tvardi to go public via merger with cash-strapped Cara

Merck & Co. boosts GLP-1 portfolio by paying $112M upfront for Hansoh’s preclinical drug

Aurion’s regenerative eye disease med improves vision in phase 1/2 trial

Cognition’s phase 2 SHIMMER results finally allow dementia drug to shine

Nvidia’s Venture Arm Raises Stake in AI Drug Discoverer Genesis Therapeutics

How the Inflammatory Process Is Influenced by the Circadian Rhythm

Novo Nordisk taps Photys for $186M cardiometabolic collab

Novo Holdings leads SiteOne’s $100M series C for non-opioid pain treatments

Ketamine Keeps Zebrafish from Giving up by Overstimulating Astroglia

BD, Babson Diagnostics expand fingertip blood draws to urgent care clinics, doctors’ offices

FDA greenlights Abbott’s wearable sensor for capturing diabetic ketoacidosis

Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its business

Labcorp launches new hepatitis D test to find patients with most severe form of virus

Implantica finally nabs FDA approval 8 years after EU green light for reflux implant